PYGO2 and neoplasm: A significant reduction was observed in tumor size and mass of the Pygo2 shRNA tumors (n=5 for Pygo2 shRNA-1 and -2 groups) compared with those of the control shRNA tumors (n=5) (Fig. 4A; P=0.005).